Lonza Group (XSWX:LONN) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


XSWX:LONN Lonza Group Ltd XSWX:LONN
82 GF Score
Price CHF528.40
GF Value CHF592.67
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lonza Group Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Lonza Group's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

XSWX:LONN vs TMO, DHR, IDXX: Margin of Safety % (DCF Earnings Based) Comparison

For the Diagnostics & Research subindustry, Lonza Group's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lonza Group Margin of Safety % (DCF Earnings Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Lonza Group's Margin of Safety % (DCF Earnings Based) falls into.


XSWX:LONN
82GF Score
Lonza Group Ltd XSWX:LONN
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lonza Group (XSWX:LONN) Overvalued in 2026?

Based on GuruFocus' analysis, Lonza Group stock appears to be undervalued. The current stock price of CHF528.40 is trading 10.8% below its estimated GF Value™ of CHF592.67. GuruFocus considers Lonza Group to be Modestly Undervalued.

Key valuation signals for XSWX:LONN:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: CHF592.67 vs. price of CHF528.40 (10.8% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the XSWX:LONN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lonza Group Business Description

Address Muenchensteinerstrasse 38, Basel, CHE, 4002
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
82GF Score

Get the complete analysis for XSWX:LONN

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF528.40
Price
CHF592.67
GF Value